8^th European Chemistry Congress 2018-08-08 June 21-23, 2018 Holiday Inn Paris – Marne La Vallée Paris, France

Dr. Feng is an expert in biochemistry and biophysics of metalloproteins. His laboratory is known for its use of multidisciplinary approaches to study molecular mechanisms of metalloproteins in medicine and toxicology. The laboratory is active in the use of cutting-edge approaches across the broad fields of chemistry, biochemistry, physics and chemical biology (including laser flash photolysis, pulsed EPR, computational chemistry and site-directed mutagenesis). The goal is to understand what the function of a biological relevant metal site is, how it goes about to achieve its function, and what factors dictate its function. His current primary research focus is on regulation mechanism of nitric oxide synthase (NOS), a flavo-hemoprotein responsible for biosynthesis of nitric oxide (NO), a ubiquitous signaling and effector molecule in mammalian cell biology. Recent studies of NOS proteins by Dr. Feng demonstrate that domain motions and interdomain docking play an important role in NOS isoform function by modulating key electron transfer processes. Molecular mechanisms of NOS regulation, once fully understood, are potentially key targets for development of selective new pharmaceuticals for treating a wide range of diseases that currently lack effective treatments. Dr. Feng has published more than 70 scientific manuscripts, is an active NIH reviewer and also serves as referee for NSF, AHA, the French National Research Agency and the Italian Ministry of Health.

Biochemistry, Biophysics and toxicology

1978 and 1999 has completed his Ph.D and D.Sci. at the ages of 33 and 54 years from Zelinsky Instiute of Organic Chemistry, Moscow, Russia and Durmishidze Institute of Biochemistry and Biotechnology, Tbilisi, Georgia, respectively. 2006 up to date he is the head of laboratory of plant biopolymers at the Tbilisi State Medical University Institute of Pharmacochemistry. 1996 and 2002 he has been a visiting scientist at Utrecht University (faculty of pharmacy), The Netherlands, by University Scholarship and The Netherlands organization for scientific research (NWO) Scholarship Scientific Program, respectively. He has published more than 80 papers in reputed journals.

Biochemistry, biotechnology,biopolymers, Pharmacochemistry and pharmacy

Dr. Janis Gravitis gained his PhD and DocSci from the the fomer USSR Academy of Science. Author and co-author of more than 300 scientific publications. Visiting Professor at the United Nations University, Institute of Advanced Studies, Tokyo, Japan, 1996–2000 Fellow of the International Academy of Wood Science Foreign Member of the International Research Centre for Sustainable Materials (Tokyo) Head of the Laboratory of Biomass Eco-Efficient Conversation, Latvian State Institute of Wood Chemistry - recently.

Wood Chemistry, Biomass Eco-Efficient Conversation, Green Chemistry

Andreia Valente obtained her PhD in 2010 from the Université de Lille I (France) in the field of Polymerization Catalysis. Since 2013, she is an Assistant Researcher at the BioOrganometallic Group at Faculty of Sciences, University of Lisbon (Portugal), where she develops her independent research based on new polymer-metal complexes as targeted drug-delivery systems in view to cancer therapy. She has published about 20 papers in reputed journals, is a Fulbright awardee, is member of the Royal Society of Chemistry and participates actively in European networks.

Polymerization Catalysis and Chemistry

Violina T Angelova has completed his PhD in 2004 from Bulgarian Academy of Sciences, Institute of Organic Chemistry with Centre of Phytochemistry, Sofia, Bulgaria. She is an Assistant Professor of Medical University of Sofia, Faculty of Pharmacy, Department of Chemistry. She has published more than 15 papers in reputed journals.

Organic Chemistry, Pharmacy

Silvia Antonia Brandán is a Faculty Biochemistry, Chemistry and Pharmacy, in Inorganic Chemistry Institute, University National of Tucumán (UNT), Tucumán, Argentina. She is Graduated in Chemistry (UNT); Chemical Engineer (UNT); PhD in Chemistry (UNT); Post-Doctorate in Alicante University, Spain. She is the Titular Professor of General Chemistry and Director of the Inorganic Chemistry Institute. She is the Editor Journal of Molecular Structure.

Biochemistry, Inorganic Chemistry and Pharmacy

Tuanli Yao has completed his PhD from Iowa State University and postdoctoral studies from University of California, Berkeley. He worked as Senior Scientist at Deciphera Pharmaceuticals and Associate Researcher at University of Kansas before beginning his career in academy. Currently, he is professor at Shaanxi University of Science & Technology. His research interests include aryne chemistry, electrophilic cyclization and palladium catalysis. He has published more than 30 papers in reputed journals.

Pharmaceuticals

Goncagul Serdaroglu has completed his PhD from Cumhuriyet University (2008) and postdoctoral studies from Auburn University (2013). Her major research interests are on structural properties and chemical behavior of biologically and pharmacologically important molecules by using computational tools.

pharmacology

Daniel T Gryko obtained his PhD from the Institute of Organic Chemistry of the Polish Academy of Sciences in 1997, under the supervision of Prof. J. Jurczak. After a Postdoctoral stay with Prof. J. Lindsey at North Carolina State University (1998–2000), he started his independent career in Poland. He became Full Professor in 2008. The same year he received the Society of Porphyrins and Phthalocyanines Young Investigator Award. His current research interests are focused on the synthesis of various functional dyes as well as on two-photon absorption, artificial photosynthesis, excited-state intramolecular proton transfer and fluorescence probes.

Organic Chemistry

Luc Jaeger has completed his PhD from the University of Strasbourg in 1993, and Postdoctoral studies from Scripps Research Institute, La Jolla, CA. He joined the faculty of the University of California Santa Barbara in 2002. He has been a visiting Professor at the National Cancer Institute, and he has held a ULP-NIBH (National Institute of Bioscience and Human Technology and Information Services) grant for work in Japan. He served as a member of the John Templeton Foundation board of advisors from 2011 to 2013. He has contributed to more than seventy papers published in scientific journals.

Bioscience, bionanotechnology and synthetic biology.